Adam Maeder
Stock Analyst at Piper Sandler
(3.85)
# 631
Out of 4,876 analysts
88
Total ratings
53.33%
Success rate
9.25%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Neutral | $3.5 → $4 | $4.30 | -6.98% | 1 | Jun 18, 2025 | |
| EW Edwards Lifesciences | Maintains: Overweight | $80 → $83 | $78.21 | +6.12% | 15 | May 13, 2025 | |
| NSPR InspireMD | Maintains: Overweight | $4.5 → $4 | $2.29 | +74.67% | 4 | May 12, 2025 | |
| TCMD Tactile Systems Technology | Downgrades: Neutral | $25 → $14 | $10.23 | +36.85% | 3 | May 6, 2025 | |
| RMD ResMed | Maintains: Neutral | $260 → $248 | $255.16 | -2.81% | 3 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $670 → $575 | $533.71 | +7.74% | 19 | Apr 23, 2025 | |
| ABT Abbott Laboratories | Reiterates: Overweight | $133 → $145 | $134.38 | +7.90% | 3 | Apr 17, 2025 | |
| RXST RxSight | Initiates: Neutral | $18 | $12.67 | +42.07% | 1 | Apr 15, 2025 | |
| RBOT Vicarious Surgical | Maintains: Neutral | $11 → $8.5 | $7.61 | +11.70% | 7 | Mar 18, 2025 | |
| INSP Inspire Medical Systems | Maintains: Overweight | $260 → $233 | $132.41 | +75.97% | 14 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $20 → $21 | $11.35 | +85.02% | 2 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 → $8 | $3.54 | +125.99% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $7.60 | +163.16% | 8 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $2.29 | +118.34% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $10 → $18 | $2.55 | +605.88% | 2 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $99 | $45.75 | +116.39% | 3 | May 5, 2022 |
Sight Sciences
Jun 18, 2025
Maintains: Neutral
Price Target: $3.5 → $4
Current: $4.30
Upside: -6.98%
Edwards Lifesciences
May 13, 2025
Maintains: Overweight
Price Target: $80 → $83
Current: $78.21
Upside: +6.12%
InspireMD
May 12, 2025
Maintains: Overweight
Price Target: $4.5 → $4
Current: $2.29
Upside: +74.67%
Tactile Systems Technology
May 6, 2025
Downgrades: Neutral
Price Target: $25 → $14
Current: $10.23
Upside: +36.85%
ResMed
Apr 24, 2025
Maintains: Neutral
Price Target: $260 → $248
Current: $255.16
Upside: -2.81%
Intuitive Surgical
Apr 23, 2025
Maintains: Overweight
Price Target: $670 → $575
Current: $533.71
Upside: +7.74%
Abbott Laboratories
Apr 17, 2025
Reiterates: Overweight
Price Target: $133 → $145
Current: $134.38
Upside: +7.90%
RxSight
Apr 15, 2025
Initiates: Neutral
Price Target: $18
Current: $12.67
Upside: +42.07%
Vicarious Surgical
Mar 18, 2025
Maintains: Neutral
Price Target: $11 → $8.5
Current: $7.61
Upside: +11.70%
Inspire Medical Systems
Feb 10, 2025
Maintains: Overweight
Price Target: $260 → $233
Current: $132.41
Upside: +75.97%
May 22, 2024
Maintains: Hold
Price Target: $20 → $21
Current: $11.35
Upside: +85.02%
Mar 6, 2024
Reiterates: Overweight
Price Target: $7 → $8
Current: $3.54
Upside: +125.99%
Mar 6, 2024
Maintains: Overweight
Price Target: $15 → $20
Current: $7.60
Upside: +163.16%
Mar 6, 2023
Maintains: Overweight
Price Target: $6 → $5
Current: $2.29
Upside: +118.34%
Jan 6, 2023
Upgrades: Overweight
Price Target: $10 → $18
Current: $2.55
Upside: +605.88%
May 5, 2022
Maintains: Overweight
Price Target: $104 → $99
Current: $45.75
Upside: +116.39%